John Barrett

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Jacques Galipeau, Mauro Krampera, John Barrett et al. · Cytotherapy · 2015 · 516 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with<i>Aspergillus</i>Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

Thomas J. Walsh, Jesse L. Goodman, Peter G. Pappas et al. · Antimicrobial Agents and Chemotherapy · 2001 · 401 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

Kate Stringaris, Takuya Sekine, A. Khoder et al. · Haematologica · 2014 · 232 citations · Full text

Life Sciences, Immunology, Oncology +17

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

Nicolás S. Piuzzi, Massimo Dominici, Marc Long et al. · Cytotherapy · 2018 · 33 citations · Full text

Veterinary Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

ABH and Lewis Antigen and Antibody Expression after Bone Marrow Transplantation

Malcolm Needs, Donald McCarthy, John Barrett · Acta Haematologica · 2009 · 19 citations

Medicine, Hematology, Immunology +17